Hereditary Angioedema
Hereditary angioedema (HAE) is a rare genetic disorder that causes recurrent episodes of severe swelling in various parts of the body, including the face, extremities, gastrointestinal tract, and airway.
Hereditary Angioedema: BW-20805 Study
We are investigating the effects and safety of BW-20805 in adults with hereditary angioedema. The study aims to see if it can help reduce the number of HAE attacks.
1-2 years≤5 visitsEfficacy phase (II)Post-Trial Drug AccessNo PlaceboInvestigational MedicinesInjectionAllergologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 70 years old?
- Do you have a diagnosis of HAE-1 or HAE-2 (a type of hereditary angioedema)?
- Have you had at least 2 HAE attacks in the last 8 weeks?
- Are you currently taking any medications for HAE attacks, like Berinert or Firazyr?
- Are you a female who can become pregnant and using birth control?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Bw-20805
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medizinische Hochschule Hannover
Klinik für Dermatologie, Allergologie und Venerologie
Laatzen, Germany
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Dermatologie
Mainz, Germany
Charite Universitaetsmedizin Berlin KöR
Institut für Allergieforschung
Teltow, Germany
Sponsor: Shanghai Argo Biopharmaceutical Co. Ltd.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.